Presentations – Cancer

Cronin-Fenton D, Dalvi T, Fryzek J, Hansen H, Hamilton-Dutoit S, Hedgeman E, Mellemgaard A, Norgaard M, Pedersen L, Potter D, Rasmussen TR, Rigas J, Shire N, Sorensen HT, Walker J. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the International Society for Pharmacoepidemiology Annual Conference, August 22-26, 2018, Prague, Czech Republic.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the American Association for Cancer Research (AACR) Annual Meeting 2018, April 14-18, 2018, Chicago, IL.

Bylsma LC, Gillezeau C, Garawin T, Kelsh M, Fryzek J, Sangare L, Lowe KA. Prevalence of RAS and BRAF Mutations in Metastatic Colorectal Cancer (mCRC) Patients by Tumor Location. Presented at the Gastrointestinal Cancers Symposium, January 18-20, 2018, San Francisco, CA.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Lawrence D, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mutations in First-Line Therapy (1L) for non-small cell lung cancer (NSCLC) patients. Presented at the 18th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) 2017, October 15-18, 2017, Yokohama, Japan.

Soff GA, Ray-Coquard I, Marfil Rivera LJ, Fryzek J, Mullins M, Bylsma LC, Park JK. Literature Review of Thrombopoietin Receptor Agonists (TPO-RA) for Chemotherapy-Induced Thrombocytopenia (CIT). Presented at the European Society for Medical Oncology 2017 Congress, September 8-12, 2017, Madrid, Spain.

Ruterbusch JJ, Bylsma LC, Fryzek J, Barlev A, et al. Bicalutamide Treatment Patterns in Elderly Prostate Cancer Patients: A Historical Cohort Study Using the Surveillance, Epidemiology and End Results Program (SEER)-Medicare Database. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, May 20-24, 2017, Boston, MA.

Fryzek JP, Ruterbusch JJ, Garabrant DH, Dalvi T, Beebe-Dimmer JL. Healthcare Resource Utilization and Costs of Care for Mesothelioma Medicare Beneficiaries. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting, May 20-24, 2017, Boston, MA.

Cronin-Fenton D , Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Mortensen K, Midta A, Shire N, Brody R, Fryzek J, Lawrence D, Rigas J, Potter D, Walker J, Mellemgaard A, Rasmussen TR, Hamilton-Dutoit S, Sorensen HT. An interim assessment of key biomarkers (programmed cell death receptor ligand 1 (PD-L1) expression and epidermal growth factor receptor (EGFR) in third-line therapy non-small cell lung cancer (NSCLC) patients: A Danish cohort study. Presented at the 41st European Society for Medical Oncology (ESMO) Congress, October 7-11 2016, Copenhagen, Denmark.

Alexander DD. Red meat and cancer risk: interpreting the evidence. Presented at the NCBA Discovery Symposium. July 27, 2016, Denver, CO.

Alexander DD. Red meat and cancer risk: interpreting the evidence. Presented at the Danish Nutrition Society; University of Copenhagen, June 21, 2016, Copenhagen, Denmark.

Fryzek J, Alexander DD, Summers N, Fraysse J, Reichert H, Townes L, Vanderpuye-Orgle J. Indirect treatment comparison of cabazitaxel for patients with metastatic castration-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen. Presented at the 21st Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 21-25, 2016, Washington, DC.

Alexander DD. Evaluating the relationship of meat and cancer risk. Presented at the Canadian Nutrition Society Conference, May 5-7, 2016, Ottawa, Canada.

Bylsma LC, Alexander DD. A Review and Meta-analysis of Prospective Studies of Red and Processed Meat, Meat Cooking Methods, Heme Iron, Heterocyclic Amines and Prostate Cancer. Presented at the Experimental Biology Conference, April 2-6, 2016, San Diego, CA.

Miller PE, Alexander DD. A Review and Meta-analysis of Prospective Studies of Red and Processed Meat and Pancreatic Cancer. Presented at the Experimental Biology Conference, April 2-6, 2016, San Diego, CA.

Alexander DD. Meat and cancer risk: understanding the science. Presented at Protein: Contributions and Controversies, February 29, 2016, Toronto, Canada.

Alexander DD. Red and processed meat consumption and cancer. Presented at the International Meat Society, July 1-2, 2015, Calgary, Canada.

Liu B, Karath SM, Sekeres MA, Fryzek JP, Mutetwa BT, Sreekantaiah C, Mason C, Kolitz, Taioli E. Insights into the spatial clustering and disease etiology of myelodysplastic syndromes. Presented at the New York City Epidemiology Forum, February 27, 2015, New York City, NY.

Kerath SM, Sekeres MA, Fryzek JP, Mutetwa BT, Sreekantaiah C, Mason CR, Kolitz J, Taioli E. Clinical characteristics and outcomes in a large sample of MDS patients. Presented at the American Public Health Association (APHA) Annual Meeting and Exposition, November 15-19 2014, New Orleans, LA.

Alexander DD. Red meat and colorectal cancer: a quantitative update on the state of the science. Presented at the Experimental Biology Annual Meeting, April 26-30, 2014, San Diego, CA.

Alexander DD. Interpreting Epidemiologic Evidence, and a Case Study on Red Meat and Colorectal Cancer. Presented at the Oncology Nutrition Symposium, January 18, 2014, Hollywood, FL.

Metha J, Le-Ruet O, Fryzek J, Iqbal U, Olivares R, Mesa R. Epidemiology of primary myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Presented at the European Cancer Congress (ESMO), September 27-October 1, 2013, Amsterdam, Netherlands.

Alexander DD. Update on Red Meat and Colorectal Cancer. Presented at the International Meat Society Annual Meeting, September 14, 2013, Granada, Spain, Webinar.

Alexander DD. Nitrate and nitrite exposure and stomach cancer: summary of the epidemiologic evidence. Presented at the Canadian Nutrition Society Annual Meeting, May 31, 2013, Quebec City, Canada.

Alexander DD. Meta-analysis: Judging the evidence, fish oil and cardiovascular disease. Presented at the AOCS: Omega-3 Fatty Acids and Heart Health, April 28-May 1, 2013, Montreal, Canada.

Tsuji JS, Alexander DD, Perez V. Low-level arsenic in drinking water and bladder cancer risk: Meta-analysis update and risk assessment implications. Presented at the Annual Meeting of the Society of Toxicology, March 10-14, 2013, San Antonio, TX.

Li J, Dalvi T, Pawaskar M, Tsai K, Caspard H, Fryzek J. Recent trends in the characteristics of patients with distant stage breast cancer in the United States Surveillance, Epidemiology and End Stage Disease program. Presented at the 2012 CTRC−AACR San Antonio Breast Cancer Symposium, December 4-8, 2012, San Antonio, TX.

Nielsen Nguyen M, Pedersen, Olesen Braae A, Wang L, Hou J, Mackey H, McCusker M, Basset-Seguin N, Fryzek J. The incidence of metastatic basal cell carcinoma in Denmark, 1997-2010. Presented at the 6th World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers in conjunction with the 8th EADO Congress, November 14-17 2012, Barcelona, Spain.

Alexander DD. A systematic review of multivitamin use and mortality, cardiovascular disease, and cancer. Presented at the Council for Responsible Nutrition (CRN): Day of Science, October 2-3, 2012, Laguna Beach, CA.

Alexander DD. Diet and cancer: Are we asking the right question? Presented at the Cancer Society of New Zealand, New Zealand Ministry of Health, Network Communications, September 11, 2012, Wellington, New Zealand.

Alexander DD. Red meat and colorectal cancer: Are we asking the right question(s)? Presented at the Diet and Gut Health Symposium, Nutrition Society of Australia, September 5, 2012, Sydney, Australia.

Kuehn C, Watson H, Ong K, Mohamed M, Ochoa JA, Fryzek J. Descriptive Epidemiology of Medical Device Use among Patients with Breast, Lung or Prostate Cancer in the National Inpatient Sample. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Alexander DD. An update on red meat and cancer. Presented at the International Congress of Meat Science and Technology (webinar), August 12-17, 2012, Montreal, Canada.

Alexander DD. Nitrate and nitrite exposure and stomach cancer: Summary of the epidemiologic evidence. Presented at the Institute of Food Technologists (IFT) Annual Meeting, June 25-28, 2012, Las Vegas, NV.

Fordyce T, Mowat F, Fryzek J, Lau E. Incidence of metastatic hormone receptor positive (HR+) breast cancer in the United Kingdom: Data Needed. Presented at the 17th Annual International Society for Pharacoeconomics and Outcomes Research, June 2-6, 2012, Washington, DC.

Alexander DD, Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX.

Yong M, Christiansen CF, Gammelager H, Sværke C, Chia V, Atchison C, Fryzek J. Healthcare resource utilization among breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1997 – 2009). Presented at the 34th Annual San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX.

Alexander DD. Nutritional epidemiology: Weighing the evidence and a case study on red meat intake and colorectal cancer. Presented at the Meat Eat Nutritional Conference, September 1, 2011, Oslo, Norway.

Alexander DD. Prevalence of bone metastasis from breast, lung or prostate cancer: A systematic and quantitative review of the literature. Presented at the International Conference on Pharmacoepidemiology, August 15-17, 2011, Chicago, IL.

Alexander DD. Benzene epidemiology: Weighing the evidence and a case study of non-Hodgkin lymphoma. Presented at the Benzene Litigation Conference Audiocast, July 13, 2011, Chicago, IL.

Alexander DD, Perez V, Cushing C, Weed DL. Red meat consumption and colorectal cancer: A meta-analysis of prospective epidemiologic studies. Presented at the 3rd North American Congress of Epidemiology, June 21-24, 2011, Montreal, Canada.

Perez V, Alexander DD, Cushing C. Processed meat consumption and stomach cancer: A meta-analysis of prospective epidemiologic studies. Presented at the 3rd North American Congress of Epidemiology, June 21-24, 2011, Montreal, Canada.

Alexander DD. Translating the science: Red meat & cancer. Presented at Ranch Event 2011, TX Beef Council, June 2, 2011, San Antonio, TX.

Nordyke RJ, Imbeah-Ampiah R, Ng-Haing J, Oshinowo B, Saraf S. Does a lack of HTA review lead to higher prices for HIV treatments? A comparison with oncology treatments. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual International Meeting, May 21-25, 2011, Baltimore, MD.

Mitchell J, Mehta J, Lau E, Fryzek J. National-level descriptive epidemiology of pediatric acute lymphoblastic leukemia. Presented at the 24th Annual Meeting of the American Society of Pediatric Hematology/Oncology, April 13-16, 2011, Baltimore, MD.

Alexander DD. Epidemiology consulting and a case study on red meat and cancer. Presented at the Distinguished Alumni Investigator Lecture, March 23, 2011, Birmingham, AL.

Alexander DD. The epidemiology of red and processed meat consumption and cancer and cardiovascular disease The role of red meats in a healthy diet: U.S Meat Export Federation, October 20, 2010, Mexico City, Mexico.

Youk AO, Buchanich JM, Marsh GM, Fryzek JP. An Ecological Study of Cancer Mortality Rates in High Altitude Counties of the United States. Presented at the Society of Epidemiological Research, June 23-26, 2010, Seattle, WA.

Alexander DD. Meat consumption and cancer: An epidemiologic overview. Presented at Live Well, Napa Valley, June 10, 2010, Napa, CA.

Beebe-Dimmer J, Schwartz KA, Cetin K, Morgenstern H, Yee C, Bartoces M, Shahinian V, Fryzek J, Acquavella J. Incidence of cataract among elderly prostate cancer patients receiving androgen deprivation therapy in the United States using the Surveillance, Epidemiology, and End Results-Medicare database. Presented at the American Society of Clinical Oncology (ASCO) Annual Conference, June 9-11, 2010, Chicago, IL.

Alexander DD. Red meat consumption and colorectal cancer: A meta-analysis of prospective studies. Presented at Experimental Biology, April 24-28, 2010, Anaheim, CA.

Alexander DD. A weight-of-evidence review of colorectal cancer in pesticide applicators: The Agricultural Health Study and other Epidemiologic Studies. Presented at CropLife America/Rise Spring Conference, April 15, 2010, Washington, DC.

Alexander DD. Meat and Cancer. Presented at the American Meat Institute, Spring Meeting. April 14, 2010, Washington, DC.

Alexander DD, Weed DL. Ongoing assessment of pesticides and colorectal cancer: A weight of evidence evaluation of epidemiologic literature. Presented at the Environmental Protection Agency SAP draft framework, February 2, 2010, Washington, DC.